TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,133,279 | +358.7% | 461,104 | +365.8% | 0.08% | +370.6% |
| Q2 2023 | $1,555,133 | -34.5% | 98,990 | -34.6% | 0.02% | -58.5% |
| Q4 2022 | $2,373,741 | -69.0% | 151,409 | -74.3% | 0.04% | -70.9% |
| Q3 2022 | $7,658,000 | +10.6% | 588,614 | +15.9% | 0.14% | +98.6% |
| Q4 2021 | $6,922,000 | +31.8% | 507,814 | +60.7% | 0.07% | +20.3% |
| Q3 2021 | $5,253,000 | -62.3% | 316,014 | -62.1% | 0.06% | -72.0% |
| Q2 2021 | $13,948,000 | +336.4% | 833,456 | +374.5% | 0.21% | +163.8% |
| Q1 2021 | $3,196,000 | -92.6% | 175,644 | -92.8% | 0.08% | -91.0% |
| Q3 2020 | $43,425,000 | -27.3% | 2,446,614 | -27.0% | 0.89% | -39.9% |
| Q2 2020 | $59,728,000 | +11.8% | 3,351,142 | -2.7% | 1.49% | -40.3% |
| Q1 2020 | $53,408,000 | +56.1% | 3,443,985 | +100.7% | 2.49% | +4350.0% |
| Q4 2019 | $34,221,000 | -21.0% | 1,716,402 | -32.3% | 0.06% | -97.4% |
| Q3 2019 | $43,306,000 | -46.5% | 2,536,884 | -44.4% | 2.14% | -27.3% |
| Q2 2019 | $80,884,000 | +184.9% | 4,563,591 | +227.8% | 2.95% | +103.5% |
| Q1 2019 | $28,391,000 | – | 1,392,335 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |